Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

GSK’s Witty ends on a high, but warns 2017 looking ‘uncertain’

Generic competition to big-selling Seretide/Advair in the US could accelerate sales decline

- PMLiVE

Denmark pitches for EMA, with help from ex Novo Nordisk CEO

Lars Rebien Sørensen to serve as special envoy to promote Danish candidacy

- PMLiVE

Claire Derbyshire joins Cello Health Insight UK

She becomes a director at the healthcare market research agency

- PMLiVE

Applied Photophysics appoints CEO

Promotes COO Louise Madden

- PMLiVE

Amgen’s chronic kidney disease drug Parsabiv cleared in US

Sensipar follow-up is the first therapy to be approved for treatment of sHPT in 12 years

- PMLiVE

Biotech leaders slam Trump over immigration order

Former Teva CEO Jeremy Levin heads open letter expressing “deep concern and opposition”

- PMLiVE

Havas Lynx boosts medical team

Dr Jack Kreindler, Dr Ben Harman-Jones and Dr Yasmin Ghani join

IFPMA appoints director general

Thomas Cueni brings expertise from Interpharma and EFPIA

- PMLiVE

NHS grows digital healthcare professionals network

Six trusts join the 250-strong hospitals currently on the web platform

- PMLiVE

Cello Health expands with Defined Health acquisition

Builds US presence with biotech-focused strategy specialist

- PMLiVE

Cellectis gets FDA nod for ‘off-the-shelf’ CAR-T trial

Investigational New Drug gets go-ahead for trials in patients with two haematological cancers

- PMLiVE

Change at the top at Teva as Vigodman departs

CEO replaced ad interim by chairman Yitzhak Peterburg as search begins

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links